端粒酶逆转录酶
端粒酶
恶性转化
逆转录酶
细胞培养
生物
端粒
癌症研究
表型
转化(遗传学)
聚合酶链反应
分子生物学
基因
遗传学
作者
Qian Tao,Biao Lv,Bin Qiao,Chao-qun Zheng,Zhifeng Chen
出处
期刊:Oral Oncology
[Elsevier]
日期:2009-12-01
卷期号:45 (12): e239-e244
被引量:20
标识
DOI:10.1016/j.oraloncology.2009.08.007
摘要
Ameloblastoma (AM) is recognized as a benign tumour but locally invasive with a high risk of recurrence. In vitro model systems for studying AM are limited due to the fact that AM cells grow poorly and begin to senesce early. Japanese researchers have reported the construction of an AM cell line, AM-1, by exposing cells to human papillomavirus 16 (HPV16) but retaining the potential of transformation. In this study, we used a retroviral infection method to over-express the human telomerase reverse transcriptase (hTERT) gene to acquire immortality of hTERT(+)-AM cells. Furthermore, it was revealed both by reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blot that the pathway of immortalization was loss of p16, not p53 or p21. Also, there was no evidence indicating that the hTERT(+)-AM cells underwent malignant transformation by the nude mouse tumorigenicity assay. Taken together, this hTERT-immortalized cell line may be a potentially valuable and reliable cell model for further study of the invasive properties of AM in vitro.
科研通智能强力驱动
Strongly Powered by AbleSci AI